ReviewCurrent treatment options in oncology2024

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL).

Zakaria Yahya Khawaji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.